Author:
Soni Vivek Kumar,Ratre Yashwant Kumar,Mehta Arundhati,Dixit Ashwini Kumar,Dwivedi Mrigendra,Shukla Dhananjay,Kumar Ajay,Vishvakarma Naveen Kumar
Reference98 articles.
1. EASL Clinical Practice Guidelines: management of hepatocellular carcinoma;EASL (European Association for the Study of the Liver);J Hepatol,2018
2. Hepatitis D and hepatocellular carcinoma;Abbas;World J Hepatol,2015
3. Pleiotrophin, a target of miR-384, promotes proliferation, metastasis and lipogenesis in HBV-related hepatocellular carcinoma;Bai;J Cell Mol Med,2017
4. Diminished viral replication and compartmentalization of hepatitis C virus in hepatocellular carcinoma tissue;Harouaka;Proc Natl Acad Sci U S A,2016
5. Mehta A, Soni VK, Shukla D, Vishvakarma NK. (2020) Cyanobacteria: a potential source of anticancer drugs. In: Advances in cyanobacterial biology. Elsevier, Academic Press, London, pp 369–384. .